Exact Sciences Corporation
EXAS
$45.66
-$1.81-3.81%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | -1.01B | -1.02B | -1.03B | -214.04M | -175.01M |
Total Depreciation and Amortization | 217.26M | 214.98M | 214.86M | 215.88M | 213.37M |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 1.11B | 1.08B | 1.08B | 239.06M | 157.19M |
Change in Net Operating Assets | -13.24M | 50.36M | -56.01M | -7.89M | -76.88M |
Cash from Operations | 305.61M | 323.66M | 210.54M | 233.02M | 118.66M |
Capital Expenditure | -135.99M | -129.51M | -135.99M | -134.60M | -133.62M |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -45.00M | -45.00M | -45.00M | -47.91M | -52.91M |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 247.86M | -130.64M | -261.17M | -284.54M | -231.77M |
Cash from Investing | 66.87M | -305.15M | -442.16M | -467.05M | -418.30M |
Total Debt Issued | 0.00 | 266.75M | 266.75M | 266.75M | 266.75M |
Total Debt Repaid | -249.17M | -50.00M | -50.00M | -50.00M | -50.00M |
Issuance of Common Stock | 30.87M | 34.24M | 34.24M | 33.84M | 32.78M |
Repurchase of Common Stock | -129.00K | -1.37M | -1.37M | -1.37M | -1.37M |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -31.99M | -270.92M | -17.75M | -17.81M | -16.44M |
Cash from Financing | -250.41M | -21.30M | 231.87M | 231.41M | 231.73M |
Foreign Exchange rate Adjustments | -984.00K | -1.86M | -3.29M | 2.37M | -734.00K |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 121.08M | -4.66M | -3.04M | -242.00K | -68.64M |